Physician profile
Susan Williams
NPI 1790742658
$2,977.39
in general payments reported to CMS, 2019-2025
19 companies · $18.17 in 2025
The $18.17 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $416 · 2021: $574 · 2022: $543 · 2023: $576 · 2024: $455 · 2025: $18.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $702.96 | 2019-2024 | Dyanavel Xr, Quillichew Er |
| Corium, LLC | $520.87 | 2021-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $393.66 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $365.79 | 2019-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Takeda Pharmaceuticals U.S.A., INC. | $281.28 | 2020-2022 | |
| Pfizer INC. | $142.00 | 2019-2024 | |
| Glaxosmithkline, LLC. | $122.81 | 2019-2022 | |
| Kaleo, INC. | $113.67 | 2019-2022 | |
| Verrica Pharmaceuticals INC. | $72.20 | 2024 | Ycanth |
| Sanofi Pasteur INC. | $65.72 | 2020-2024 | |
| Supernus Pharmaceuticals, INC. | $48.59 | 2021-2022 | |
| Shire North American Group INC | $39.26 | 2019 | |
| Cranial Technologies, INC | $19.72 | 2022 | |
| Abbott Laboratories | $18.17 | 2025 | Freestyle Libre 3 |
| Genentech USA, INC. | $16.59 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.38 | 2019 | |
| Sobi, INC | $14.23 | 2023 | |
| Adlon Therapeutics L.P. | $12.60 | 2020 | |
| Phadia US INC. | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.